A promising advance for patients with uveal #melanoma. Early real-world outcomes show the HEPZATO Kit continuing to improve results after FDA approval, offering a targeted liver-directed treatment for this rare eye cancer.
#CancerResearch #Oncology #TCSC #eyecancer
www.moffitt.org/endeavor/arc...